Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can online peer support help women with HIV and trauma stay on track?

NCT ID NCT05509959

Disease control Sponsor: University of California, San Diego Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is testing a program called Women SHINE, which uses online peer support sessions and group therapy to help women living with HIV who have experienced interpersonal violence. The goal is to see if this approach helps them take their HIV medication more consistently and improves their emotional well-being. The study will enroll 360 women and compare the program to a single group session plus a resource website.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Behavioral intervention: peer navigation sessions and support groups
What this could lead to
If successful, this program could provide an effective way to improve HIV medication adherence and mental health for women who have experienced trauma.
What could go wrong
This is a relatively small, early-stage behavioral study. The results may not apply to all women with HIV, and the program may not work better than the control group.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 360 people

The number the study aims to enrol. It can still change while the study runs.

Started

Nov 2022

Expected to finish

Sep 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Cisgender female * Diagnosis of HIV by a physician, healthcare provider, or community health worker * Aged 18 years or older * Speaking and reading English or Spanish * Adulthood experiences of interpersonal violence * Currently prescribed ART * Self-report of \<90% past-month ART adherence * Not currently participating in another adherence intervention * Access to an internet browser Exclusion Criteria: * Unwillingness to participate in the intervention * Transgender female * No diagnosis of HIV by a physician, healthcare provider, or community health worker * Aged less than 18 years * Not speaking and reading English or Spanish * Not currently prescribed ART * Self-report of \>= 90% past-month ART adherence * Currently participating in another adherence intervention * No access to an internet browser * Cognitive impairment limiting the ability to provide informed consent * Experiencing only childhood experiences of interpersonal violence * Inability to safely participate in the study based on secondary screener

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIV/AIDS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

AIDS

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HIV/AIDS

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • The Regents of the Univ. of Calif., U.C. San Diego

    RECRUITING

    La Jolla, California, 92093, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.